Fairvalue-Calculator Fairvalue-Calculator
EN DE

MediPharm Labs Corp (LABS) Fair Value & Analysis

Healthcare · CA · Market cap C$29.7M

PriceC$0.0700
Fair ValueC$0.0490
Upside-30.0%
Quality95/100
Evidence: Low Range C$0.0420 – C$0.0560

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

MediPharm Labs Corp (LABS) currently trades at C$0.0700, while our model-based Fair Value estimate is C$0.0490 — implying the stock looks roughly 30.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +885% Jiangsu Hengrui Pharmaceuticals Co (600276) -44% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -75% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -78%

Frequently asked questions

Is MediPharm Labs Corp (LABS) undervalued?
As of Jun 26, 2026, our model estimates a fair value of C$0.0490 versus a price of C$0.0700 — about −30% (overvalued). Model-based estimate, not financial advice.
What is the fair value of LABS?
Our 21-model fair value for MediPharm Labs Corp is C$0.0490 (as of Jun 26, 2026), built from audited fundamentals. The current price is C$0.0700.
What is the quality score of LABS?
MediPharm Labs Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.